Validation of targeted next‐generation sequencing of cell‐free DNA from archival cerebrospinal fluid specimens for the detection of somatic variants in cancer involving the leptomeninges: Cytopathologic and radiographic correlation

Next-generation Sequencing of Cerebrospinal Fluid for Clinical Molecular Diagnostics in Pediatric, Adolescent and Young Adult (AYA) Brain Tumor Patients

(2022) Alexandra M Miller et al.   NEURO-ONCOLOGY

Residual ctDNA after treatment predicts early relapse in patients with early-stage non-small cell lung cancer

(2022) D. Gale et al.   ANNALS OF ONCOLOGY

Clinical Experience of Cerebrospinal Fluid–Based Liquid Biopsy Demonstrates Superiority of Cell-Free DNA over Cell Pellet Genomic DNA for Molecular Profiling

(2021) Tejus A. Bale et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Detection of Leptomeningeal Disease Using Cell-Free DNA From Cerebrospinal Fluid

(2021) Michael D. White et al.   JAMA Network Open

Detection of clonotypic DNA in the cerebrospinal fluid as a marker of central nervous system invasion in lymphoma

(2021) Adam J Olszewski et al.   Blood Advances

Serial assessment of measurable residual disease in medulloblastoma liquid biopsies

(2021) Anthony P.Y. Liu et al.   CANCER CELL

Cell free circulating tumor DNA in cerebrospinal fluid detects and monitors central nervous system involvement of B-cell lymphomas

(2020) Sabela Bobillo et al.   HAEMATOLOGICA

Liquid Biopsy of Non-Plasma Body Fluids in Non-Small Cell Lung Cancer: Look Closer to the Tumor!

(2020) Lucile Durin et al.   Cells

Ancillary molecular testing of indeterminate thyroid nodules

(2018) Esther Diana Rossi et al.   CANCER CYTOPATHOLOGY

Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer

(2017) Marilyn M. Li et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Evaluating Cancer of the Central Nervous System Through Next-Generation Sequencing of Cerebrospinal Fluid

(2016) Elena I. Pentsova et al.   JOURNAL OF CLINICAL ONCOLOGY

Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma

(2015) Leticia De Mattos-Arruda et al.   Nature Communications

Recurrent targets of aberrant somatic hypermutation in lymphoma

(2015) Alireza Hadj Khodabakhshi et al.   Oncotarget

Leptomeningeal metastases in the MRI era

(2010) J. L. Clarke et al.   NEUROLOGY